z-logo
Premium
Functional defect in regulatory T cells in myasthenia gravis
Author(s) -
Thiruppathi Muthusamy,
Rowin Julie,
Li Jiang Qin,
Sheng Jian Rong,
Prabhakar Bellur S.,
Meriggioli Matthew N.
Publication year - 2012
Publication title -
annals of the new york academy of sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.712
H-Index - 248
eISSN - 1749-6632
pISSN - 0077-8923
DOI - 10.1111/j.1749-6632.2012.06840.x
Subject(s) - foxp3 , myasthenia gravis , immunology , immune system , immunosuppression , microbiology and biotechnology , t cell , biology , regulatory t cell , in vitro , pathogenesis , immune tolerance , il 2 receptor , genetics
Forkhead box P3 (FOXP3) is a transcription factor necessary for the function of regulatory T cells (T reg cells). T reg cells maintain immune homeostasis and self‐tolerance and play an important role in the prevention of autoimmune disease. Here, we discuss the role of T reg cells in the pathogenesis of myasthenia gravis (MG) and review evidence indicating that a significant defect in T reg cell in vitro suppressive function exists in MG patients, without an alteration in circulating frequency. This functional defect is associated with a reduced expression of key functional molecules, such as FOXP3 on isolated T reg cells, and appears to be more pronounced in immunosuppression‐naive MG patients. In vitro administration of granulocyte macrophage–colony‐stimulating factor (GM‐CSF) enhanced the suppressive function of T reg cells and upregulated FOXP3 expression. These findings indicate a clinically relevant T reg cell–intrinsic defect in immune regulation in MG that may reveal a novel therapeutic target.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom